Future Leaders Biographies

Arthur Beyder

Arthur Beyder, MD, PhD
Senior Associate Consultant, Division of Gastroenterology & Hepatology
Assistant Professor, Departments of Medicine & Physiology and Biomedical Engineering
Mayo Clinic, Rochester, MN

Art Beyder grew up one of 3 children in the former USSR and emigrated with his family to United States in 1989. He spent the next 20 years in Buffalo, NY. There, amongst other things, he learned about chicken wings and American football. Art came to "the other" Rochester in 2007 and all of his 4 children are Minnesotans.

Dr. Beyder graduated summa cum laude in biophysics and mathematics from the State University of New York (SUNY) Buffalo in 1998. He stayed at SUNY Buffalo for medical scientist training program (MSTP) training. Dr. Beyder's graduate thesis with Dr. Fred Sachs, who discovered mechanosensitive ion channels, dealt with the molecular aspects of electro-mechanical coupling. Dr. Beyder finished MD-PhD training in 2007 and between 2007 and 2014 he did post-graduate training in the clinician-investigator (CI) program at the Mayo Clinic. During this time, Dr. Beyder completed clinical training as a resident in internal medicine and a fellow in gastroenterology & hepatology, as well as post-doctoral training with Dr. Gianrico Farrugia pursuing the basic underpinnings of gastrointestinal motility. Dr. Beyder has been on staff at the Mayo Clinic as a clinician-scientist since 2014.

Dr. Beyer runs a NIH-funded basic and translational science laboratory that explores the relevant molecular pathways in gastrointestinal (GI) motility disorders. His research laboratory is particularly interested in understanding how ion channel proteins are involved in electro-mechanical and mechano-electrical coupling in GI motility and functional GI disorders. The work in the laboratory spans a wide range of experimental techniques with studies from single molecules to living organisms. Studies typically start from determining the precise localization of ion channels in specific cell types within the gastrointestinal tract, then understanding function using electrophysiology in single cells and tissues, and finally examining in vivo function in rodents and humans. The result of this work is that a novel field - ion channelopathies, or diseases due to abnormal ion channel function, provided mechanistic explanation for cohorts of patients with functional GI diseases. Both intellectual and technical innovation are critical for success and reflected by Dr. Beyder's group holding several US patents and work published in PNAS, Circulation, Gastroenterology and Journal of Physiology among others.

Brigid Boland

Brigid S. Boland, MD
Assistant Professor of Medicine
University of California, San Diego, La Jolla, CA

Brigid S. Boland, MD, is an assistant professor of medicine in the inflammatory bowel disease center at the University of California, San Diego. 

Dr. Boland has a focus on translational research in inflammatory bowel disease (IBD) and helped develop a robust inflammatory bowel disease biorepository at the University California, San Diego.  She has an interest in developing methodology for future mechanism-of-action studies and early proof-of-concept studies in IBD, and her current research focuses on identifying biomarkers in IBD to predict response to therapies.  She has a Crohn’s and Colitis Foundation of America Career Development Award and was recently awarded a KL2 to study biomarkers to predict clinical and endoscopic response to vedolizumab in ulcerative colitis and Crohn’s disease.

Dr. Boland is a member of the AGA, and she is currently a member of the Research Committee as well as the Trainee and Young Gastroenterologist Committee.

She received her undergraduate degree from Yale University and her medical degree from the University of California, San Francisco.  She completed her internal medicine and gastroenterology fellowship at the University of California, San Diego.  After a post-doctoral fellowship in the immunology laboratory of John Chang, MD, she completed a year of advanced clinical and research fellowship in inflammatory bowel disease under the mentorship of Dr. William Sandborn, MD.  She joined the faculty at the University of California, San Diego in 2015.

B. Chumpitazi

Bruno P. Chumpitazi, MD, MPH
Director, Neurogastroenterology and Motility Program
Texas Children's Hospital/ Baylor College of Medicine, Houston, TX

Dr. Bruno Chumpitazi is a pediatric gastroenterologist and Director of the Neurogastroenterology and Motility Program at Texas Children’s Hospital. His clinical and research interests include: chronic nausea, gastroparesis, irritable bowel syndrome, Hirschsprung’s disease, fecal incontinence, dietary interventions, and the gut microbiome.

Dr. Chumpitazi completed medical school at Tufts University School of Medicine, his pediatric residency at Children’s Hospital New York Presbyterian, and his pediatric gastroenterology fellowship at Children’s Hospital Boston prior to coming to Texas Children’s Hospital.

Dr. Chumpitazi is a member of the Center for Pediatric Abdominal Pain Research and collaborates with Texas Children’s Microbiome Center. His research focuses on diagnosing and treating children with functional abdominal pain, irritable bowel syndrome and dyspepsia. Dr. Chumpitazi is especially interested in the role of diet in causing abdominal pain symptoms.

B. Katona

Bryson Katona, MD, PhD
University of Pennsylvania, Philadelphia, PA

Dr. Bryson Katona is currently an Instructor of Medicine in the Division of Gastroenterology at the Perelman School of Medicine at the University of Pennsylvania, where he serves as the director of the Gastrointestinal Cancer Genetics Program.  Dr. Katona is a physician-scientist with clinical and research interests in the fields of gastrointestinal cancer and cancer genetics.  His NIH K08-funded basic science research program is focused on epigenetic regulatory mechanisms in colon cancer and neuroendocrine tumors, and the ways in which these mechanisms can be modulated to aid in the development of novel therapeutic strategies for these cancers.  His clinical interests are in hereditary gastrointestinal cancer and polyposis syndromes. 

Dr. Katona currently serves as the Editor-in-Chief of The New Gastroenterologist.  He has also served on the AGA Publications Committee as well as the AGA Trainee and Early Career Committee.  Dr. Katona received his BA and MS in chemistry from the University of Pennsylvania, and then completed his MD and PhD in biochemistry at Washington University in St. Louis.  He then completed his internal medicine residency and gastroenterology fellowship at the University of Pennsylvania.  

C. HAChristina Y. Ha, MD
Assistant Professor of Medicine
University of California, Los Angeles
David Geffen School of Medicine, Santa Monica, CA

Christina Ha, MD, graduated magna cum laude from Harvard University and earned her medical degree from Albert Einstein College of Medicine. She completed both her internal medicine residency and gastroenterology fellowship at Washington University in St. Louis School of Medicine. Following GI fellowship, she spent a year as the Present-Levison Inflammatory Bowel Disease Fellow at the Mount Sinai School of Medicine in New York. Subsequently, she joined the faculty at The Johns Hopkins School of Medicine as part of the Meyerhoff Inflammatory Bowel Disease Center prior to joining the Vatche and Tamar Manoukian Division of Digestive Diseases in 2013. At University of California Los Angeles (UCLA), she is the associate director of clinical programs at the Center for Inflammatory Bowel Diseases. 

Her areas of clinical interest are IBD, Crohn's disease and ulcerative colitis, with a particular focus on the natural history and outcomes of IBD in the older patient population. She has also been active in trainee and patient education institutionally and within the GI societies, serving on multiple committees within the Crohn's & Colitis Foundation of America (CCFA), American College of Gastroenterology and AGA.  She was awarded the Green Apple Junior Faculty Teaching Award by the Division of Digestive Diseases at UCLA as well as an AGA Academy of Educators Small Grant.  She has served as the chair of the AGA Graduate Training Examination Subcommittee and of the CCFA’s junior faculty interest group – Rising Educators, Clinicians and Academic Helping IBD (REACH-IBD).    


Folasade (Fola) P. May, MD, PhD, MPhil
Assistant Professor of Medicine
David Geffen School of Medicine at the University of California, Los Angeles Department of Veterans Affairs, Los Angeles, CA

Dr. May is an Assistant Professor of Medicine in the Division of Digestive Disease at the University of California Los Angeles (UCLA) and a staff physician in Gastroenterology in the Greater Los Angeles Veterans Affairs Healthcare System.

Dr. May graduated from Yale University with a degree in Molecular, Cellular, and Developmental Biology and then obtained a Masters in Epidemiology from the University of Cambridge (UK). She attended Harvard Medical School and trained in internal medicine at Massachusetts General Hospital before joining the UCLA Specialty Training and Advanced Research (STAR) Program, completing a fellowship in gastroenterology at UCLA and a PhD in Health Policy and Management from the UCLA Fielding School of Public Health. The focus of her doctoral thesis was black-white disparities in colorectal cancer incidence and outcomes.

Currently, Dr. May is a general gastroenterologist in the VA, member of the UCLA Jonsson Comprehensive Cancer Center, health services research in the UCLA Center for Cancer Prevention Control Research, and co-director of the UCLA STAR program. She is involved in research and public health efforts to improve colon cancer awareness and colon cancer screening in the U.S population at large, and especially in underserved populations where screening rates are lowest. 


Jennifer M. Weiss, MD, MS
Assistant Professor of Medicine, Division of Gastroenterology and Hepatology
Director, UW Gastroenterology Genetics Clinic
University of Wisconsin School of Medicine and Public Health, Madison, WI

Jennifer Weiss, MD, MS is an Assistant Professor in the Department of Medicine, Division of Gastroenterology and Hepatology at the University of Wisconsin, Madison, WI.

Dr. Weiss’s clinical and research interests focus on colorectal cancer screening for both average-risk and high-risk populations.  She is an American Cancer Society funded researcher who is evaluating system-wide interventions to increase colorectal cancer screening rates and develop a toolkit to guide other healthcare systems in their colorectal cancer screening program design efforts.  Her future research plans involve training in dissemination and implementation science to prepare her toolkit for a larger hybrid effectiveness-implementation trial.  Dr. Weiss also dedicates her time to patients at high-risk for colorectal cancer as the Director of the UW Gastroenterology Genetics Clinic and looks forward to expanding her research program to include this population.

Dr. Weiss has been a member of the AGA since her first year of gastroenterology fellowship and has served on the AGA Ethics Committee for the past three years.  She is excited to be part of the AGA Future Leaders Program and have the opportunity to give back to the AGA.  Dr. Weiss is also active in the National Colorectal Cancer Roundtable and on the National Comprehensive Cancer Network Colorectal Cancer Screening and Colon Genetics Guideline Committee.

She received her undergraduate degree from Cornell University in Ithaca, NY and her medical degree from the University of Rochester School of Medicine and Dentistry in Rochester, NY.  Dr. Weiss then completed her internship, residency, and fellowship at the University of Wisconsin School of Medicine and Public Health in Madison, WI.  During her fellowship she received a master’s degree in Population Health Sciences from the UW and then completed a T32 post-doctoral fellowship from the Agency for Healthcare Research and Quality on Health Services Research and Healthcare Quality Improvement prior to her current faculty appointment.


N. Jewel Samadder, MD, MSc
Assistant Professor of Medicine
Huntsman Cancer Institute, Salt Lake City, UT

Dr. Samadder received his medical degree from the University of Toronto (Canada) where he also completed his internal medicine residency. He subsequently completed a fellowship in Gastroenterology at the University of Michigan (Ann Arbor, MI) and an Advanced Endoscopy fellowship at the Mayo Clinic (Rochester, MN). During his gastroenterology fellowship, Dr. Samadder also completed his Master’s in Healthcare Research at the University of Michigan Medical School and obtained specialized training in Cancer Genetics at the University of Michigan Comprehensive Cancer Center under the mentorship of Dr. Stephen Gruber. He is a Fellow of the Royal College of Physician and Surgeons in Canada. 

His research focuses on the genetic epidemiology and chemoprevention clinical trials in patients with hereditary colorectal and pancreatic cancer.  Dr. Samadder has published and presented at national meetings on the increased risk of colorectal cancer associated with various genetic, lifestyle factors (smoking, alcohol consumption) and chronic diseases (diabetes, inflammatory bowel disease) and opportunities for chemoprevention. He recently led an NCI funded clinical trial examining the use of erlotinib for prevention of small bowel cancer in patients with familial adenomatous polyposis (FAP) which was highly positive and led a publication in the prestigious medical journal, JAMA.  

Dr. Samadder’s special interests are in the areas of hereditary gastrointestinal cancer and endoscopic oncology. He performs both general and therapeutic endoscopy.

JRJonathan A. Rosenberg, MD
Illinois Gastroenterology Group, Highland Park, IL

Dr. Rosenberg is a partner in the Illinois Gastroenterology Group, the largest independent gastroenterological private practice in Illinois and the sixth largest in the country. He received his medical degree from the University of Illinois College of Medicine and completed his internship and residency in internal medicine at the University of Illinois Medical Center in Chicago. Dr. Rosenberg completed his fellowship training in gastroenterology at the University of Chicago and an advanced therapeutic endoscopy fellowship at the University of Illinois Medical Center.

Rosenberg is Medical Director of SonarMD, LLC, which is committed to the development of patient engagement tools and care algorithms for the management of patients with chronic disease. He also serves on the American Gastroenterological Association Institute Quality Measures Committee and is the Vice President of the Board of Directors for the Lake County Physicians’ Association, an Independent Practice Association.


Katherine S. Garman, MD
Assistant Professor of Medicine
Duke University Medical Center, Durham, NC 

Dr. Katherine Garman is an Assistant Professor of Medicine at Duke University in the Division of Gastroenterology. She is a practicing gastroenterologist with clinical focus on luminal GI disease. The Garman lab studies gastrointestinal injury, repair and carcinogenesis. It is a translational research lab and the science is based in observations from human health and disease. The group actively recruits patients to participate in a GI tissue repository, through which we bank well-clinically annotated patient samples from the endoscopy suite and the operating room. The group uses banked samples to study the gastrointestinal tract in different states: healthy, inflamed or damaged, and with cancer.  In addition, the group has developed new models order to better understand pathways involved in esophageal damage and repair; these models include 3D cell culture models and a porcine model of esophageal injury and repair. As PI for the Duke Gastroenterology Tissue Repository, Dr. Garman also collaborates with groups performing translational gastrointestinal research in cancer diagnostics and inflammatory bowel disease. In addition to her research interests, Dr. Garman is an advocate for women’s leadership in gastroenterology, and has co-chaired the AGA’s Women’s Leadership Conference in 2016 and 2017. Dr. Garman also has an interest in health and wellness of the endoscopist and is a member of the AGA’s Ergonomics Task Force. She is proud to be included in the 2017-2018 AGA Future Leader’s Class.   

Lea Chen

Lea Ann Chen, MD
Assistant Professor of Medicine
New York University School of Medicine, New York, NY

Lea Ann Chen, MD, is an assistant professor of medicine at New York University. She specializes in treating patients with inflammatory bowel disease (IBD) and the use of fecal microbiota transplantation. Her research is focused on the role of the gut microbiome in gastrointestinal diseases, and her work has been supported by sources such as the ACG Pilot Research Award, the Colton Family Scholar award, and the AGA-Takeda Pharmaceuticals International Research Scholar Award in Gut Microbiome Research.

Dr. Chen is a member of the NYU Human Microbiome Program and is the Vice President of the New York Crohn’s and Colitis Organization (NYCCO), a local consortium dedicated to collaborative IBD research and education.  She serves on the steering committee of REACH-IBD, the junior faculty arm of the Crohn’s and Colitis Foundation of America. Dr. Chen has received several distinctions, including the Daniel Ford National Housestaff Research Award, the Salix Fellowship to Leadership Award, and the inaugural Sherman Emerging Leader Prize for Excellence in Crohn’s and Colitis.             

Dr. Chen graduated with honors from Rice University where she majored in Policy Studies and in Biology, with a focus in Ecology and Evolutionary Biology. She completed her medical degree at Washington University School of Medicine in St. Louis, her internal medicine residency at Mount Sinai Hospital in New York City, and her gastroenterology fellowship in the T32-supported physician-scientist track at Johns Hopkins School of Medicine. 

MVR Maria Vazquez Roque, MD, MSc
Mayo Clinic, Jacksonville, FL

Dr. Vazquez Roque was born in San Juan, Puerto Rico. She did all of her undergraduate studies at the University of Puerto Rico where she graduated with honors. In 2003, she completed her medical degree at the University of Puerto Rico Medical Sciences Campus. During her residency she pursued a Master of Biomedical Sciences in clinical research at the Mayo Clinic Graduate School in Rochester, Minnesota under the mentorship of Dr. Michael Camilleri. She completed her master’s degree in 2006 and defended her thesis on gastric sensory and motor functions in obesity in 2007. She completed her internal medicine residency in Puerto Rico in 2008. She then pursued a Gastroenterology fellowship in the NIH training grant at Mayo Clinic Rochester, Minnesota. During her GI fellowship she continued working with her mentor Dr. Camilleri. During her training, she participated in research studies in functional GI disorders and IBS. During this time she worked with IBS and gluten related disorders.

After graduating from GI fellowship, she began to work in the Division of Gastroenterology and Hepatology at Mayo Clinic Florida in April 2012. She currently is an Assistant Professor and is the Endoscopy chair for the Division of Gastroenterology and Hepatology in Mayo Clinic Florida. At the present time, she is working on several research studies and was awarded research funding from Mayo Clinic to pursue further studies in understanding the role of the intestinal barrier in gluten sensitive patients with functional GI disorders.  In addition, she also started the Fecal Microbiota Transplant program at the Mayo Clinic Florida campus for patients who suffer from recurrent episodes of Clostridium difficile infection. 


Marty M. Meyer, MD
The Ohio State University, Columbus, OH

Marty M. Meyer is a board-certified gastroenterologist practicing at The Ohio State University Wexner Medical Center.  He completed his undergraduate work at the University of Notre Dame and then returned home to Ohio State for medical school.  Dr. Meyer completed medical school, internal medicine and gastroenterology training at Ohio State, and has been a member of the faculty since 2009.  His primary clinical focus is luminal disorders including celiac disease, inflammatory bowel disease and malabsorption syndromes.  He also emphasizes his role as an educator and has been the program director of the gastroenterology fellowship program since 2014.  Additional administrative positions include Section Head of Comprehensive Gastroenterology and Director of Video Capsule Endoscopy. He sits on the Training Committee for the American College of Gastroenterology and is an active member of the American Gastroenterological Association Academy of Educators.  His research endeavors include clinical outcomes for specialized patient populations undergoing video capsule endoscopy as well as patient safety indicators for sedation during endoscopy.

Dr. Meyer has been married for 14 years to his college sweetheart, Lisa.  They reside in Dublin, OH and are busy raising three children ages 11, 9 and 5.  In his spare time, he attends his daughters’ various dance competitions and tries to play golf.  He and his family love visiting Myrtle Beach and Disney World.


Matthew A. Ciorba, MD
Assistant Professor of Medicine
Director of Research, Inflammatory Bowel Disease Program
Associate Director, GI Fellowship Program (T32 Research)
Washington University in St. Louis, Saint Louis, MO

Matthew Ciorba, MD, is a physician scientist with a research program dedicated to advancing care in the Inflammatory Bowel Diseases (IBD) and colon cancer. His clinical expertise is in improving the quality of life for patients with Crohn’s disease and ulcerative colitis, colon cancer prevention and managing the GI symptoms complicating cancer therapy. He has led several investigator-initiated, NIH-funded and industry-sponsored clinical research related to these diseases.

Dr Ciorba’s basic-translational research program examines how microbiota and metabolism impact GI health. His group’s mission is to define the mechanisms and means by which the tryptophan metabolism pathway and probiotic bacteria can be exploited to treat and prevent GI inflammation and cancer.

Dr Ciorba is also deeply committed to training the next generation of physicians and scientists to further advance the discovery and treatment of these important diseases. Supporting this mission, he is the director of research in the IBD Program, associate director of the GI Fellowship focused on the T32 and research training and participates in training grant review committees for several organizations including AGA, Crohn’s and Colitis Foundation of America and NIH.

Peter L

Peter S. Liang, MD, MPH
NYU/Manhattan VA, New York, NY 

Peter S. Liang, MD, MPH, is an instructor at the New York University School of Medicine and an attending physician at the VA New York Harbor Healthcare System, New York, NY.

Dr. Liang’s primary research interest is colorectal cancer prevention. He studies sociodemographic and geographic disparities in colorectal cancer screening and outcomes, the comparative effectiveness of different screening strategies, and novel methods to increase screening adherence. He also maintains interests in gastric cancer prevention and the management of upper gastrointestinal bleeding.

Dr. Liang completed his undergraduate degrees in Biological Sciences and East Asian Studies with honors and distinction at Stanford University and was a Fulbright Fellow in China. He attended Harvard Medical School and earned a master’s in public health in Quantitative Methods at the Harvard School of Public Health. He completed his internal medicine residency at Brigham and Women’s Hospital and his gastroenterology fellowship at the University of Washington. Dr. Liang serves on the AGA Publications and Trainee and Early-Career GI Committees as well as the Clinical Practice abstract review committee.

SW Sachin Wani, MD
Associate Professor of Medicine
Medical Director Esophageal & Gastric Center
University of Colorado Anschutz Medical Center, Aurora, CO

Dr. Wani is an Associate Professor in Medicine in the Division of Gastroenterology and Hepatology at the University of Colorado. He obtained his medical degree from the Dr. D.Y. Patil Medical College, Mumbai, and completed his Internal Medicine Residency training at Lincoln Medical Center, New York.  He then completed his Gastroenterology and Hepatology Fellowship at the University of Kansas School of Medicine followed by Advanced Therapeutic Endoscopy Fellowship at Washington University in St. Louis.

His clinical and research interests are in the field of Barrett’s esophagus and early esophageal cancer, advanced imaging, endoscopic outcomes research, endoscopic ultrasound and training and competency in advanced endoscopy training.  He received the American College of Gastroenterology (ACG) Clinical Research Award, the American Gastroenterology Association—Takeda Research Scholar Award in Barrett’s esophagus and GERD and the University of Colorado Department of Medicine Early Scholars Award and recently the American Society for Gastrointestinal Endoscopy Endoscopic Research Award.  He serves as a member of the ACG Research Committee, the American Society for Gastrointestinal Endoscopy (ASGE) Standards of Practice Committee, and the American Gastroenterology Association Guidelines, Research and Center for GI Innovation and Technology Committees.

He is married to Anuja and has twin boys, Kaahan and Krish.  In his free time, he enjoys spending time with his kids, traveling, and tennis.   

SSSiddharth Singh, MD, MS
Assistant Professor of Medicine
University of California, San Diego, La Jolla, CA

Siddharth Singh, MD, MS, is an Assistant Professor of Medicine in the Division of Gastroenterology at University of California San Diego, with a clinical and research focus on Inflammatory Bowel Diseases. He graduated from medical school from the All India Institute of Medical Sciences in New Delhi, followed by residency at University of Iowa, and gastroenterology as well as advanced fellowship in Inflammatory Bowel Diseases from Mayo Clinic in Rochester. He subsequently joined UCSD in the Division of Gastroenterology in 2015, and is also pursuing NIH-funded training in Clinical Informatics in the Division of Biomedical Informatics at UCSD. Dr. Singh’s research interests are two fold: (a) comparative effectiveness research and population health management for high value care in inflammatory bowel diseases, and (b) identifying modifiable predictors of disease course and response to therapy, such as obesity. Through his Masters’ in Clinical and Translational Science at Mayo Clinic and postdoctoral training in Clinical Informatics at UCSD, Dr. Singh has developed a unique skill set in big data analysis including secondary analysis of clinical trials, administrative datasets and electronic medical records to identify and phenotype disease-based cohorts through natural language processing and privacy-preserved data sharing and integration, knowledge synthesis using systematic reviews and meta-analyses, and guideline development. He is actively engaged in the AGA in developing clinical practice guidelines as a GRADE methodologist leading IBD-focused guidelines. He is also engaged in developing electronic health record-integrated clinical decision support tools to enable effective and efficient implementation and measurement. He has authored over 80 research articles in leading journals including JAMA, the British Medical Journal and Gastroenterology, and will be an Associate Editor for Clinical Gastroenterology and Hepatology starting summer 2017. He is a self-confessed foodie and can stay up all night to watch cricket. 


Susan N. Ramdhaney, MD, AGAF
Comprehensive Digestive Care, Manhasset, NY

Susan Ramdhaney MD, president of Comprehensive Digestive Care, practices within a six-member GI group in a multicultural and multiethnic community in metropolitan Long Island and Queens, New York. She has special interest in the health of women and minority groups.

Dr. Ramdhaney was awarded the Hugh Brock Entrance Scholarship to McGill University, Canada where she completed her undergraduate degree in Biochemistry. During that time, she worked as a research associate at the Montreal Neurological Institute in the Muscular Dystrophy Division. Growing up in the Caribbean, Dr. Ramdhaney developed a keen interest in contributing to the improvement of medical services in underdeveloped countries. In 1997 she was awarded the International Peace Scholarship from St George’s University School of Medicine in Grenada where she completed her medical degree. Upon graduation she worked as a research coordinator at Maimonides Medical Center. Her work on the prevention of post-ERCP pancreatitis and reducing mortality in upper GI bleeding is now published. She completed an Internal Medicine Residency in Brooklyn, NY, at Maimonides Medical Center and later a gastroenterology fellowship at the State University of New York, Downstate. Dr. Ramdhaney is the author and co-author of several chapters and articles, including the “Endoscopic Techniques in the Management of Thoracic Diseases - Shields and Locicero’s General Thoracic Surgery” textbook, as well as four chapters in the “Curbside Consultation of the Pancreas”.

Following the completion of her gastroenterology fellowship, Dr. Ramdhaney joined a private group at Brooklyn Gastroenterology and Endoscopy where she became Director of the Women’s Health Institute. She continued to travel to the Caribbean investigating health care models and began educating in Guyana on the importance of screening for colorectal cancer. She was listed in Superdoctors as New York Rising Star both in 2013 and in 2014. In 2014, Dr. Ramdhaney established Comprehensive Digestive Care and managed her practice in Long Island, NY. She is now practicing within a group in the area and is spearheading the establishment of their Women’s Health Center.

Recently, Dr. Ramdhaney was given the honor of being inducted into the AGA Fellowship.